Nanogel: A versatile drug delivery system for the treatment of various diseases and their future perspective
Drug Delivery and Translational Research · 2025-02 · 15 (2) · 455-482
DOI: 10.1007/s13346-024-01684-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 05.08.2024. Verfasst von Jitendra Gupta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India. jitendra.gupta@gla.ac.in. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanogels. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 215 Literaturangaben.
Abstract (Originalsprache)
Nanogel (NG) drug delivery systems have emerged as promising tools for targeted and controlled drug release, revolutionizing treatment approaches across various diseases. Their unique physicochemical properties, such as nano size, high surface area, biocompatibility, stability, and tunable drug release, make them ideal carriers for a wide range of therapeutic agents. Nanogels (NGs), characterized by their 3D network of crosslinked polymers, offer unique edges like high drug loading capacity, controlled release, and targeted delivery. Additionally, the diverse applications of NGs in medical therapeutics highlight their versatility and potential impact on improving patient outcomes. Their application spans cancer treatment, infectious diseases, and chronic conditions, allowing for precise drug delivery to specific tissues or cells, minimizing side effects, and enhancing therapeutic efficacy. Despite their potential, challenges such as scalability, manufacturing reproducibility, and regulatory hurdles must be addressed. Achieving clinical translation requires overcoming these obstacles to ensure therapeutic payloads' safe and efficient delivery. Strategies such as surface modification and incorporating stimuli-responsive elements enhanced NG performance and addressed specific therapeutic challenges. Advances in nanotechnology, biomaterials, and targeted drug design offer opportunities to improve the performance of NGs and address current limitations. Tailoring NGs for exploring combination therapies and integrating diagnostics for real-time monitoring represent promising avenues for future research. In conclusion, NG drug delivery systems have demonstrated tremendous potential in diverse disease applications. Overcoming challenges and leveraging emerging technologies will pave the way for their widespread clinical implementation, ushering in a new era of precision medicine and improved patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India. jitendra.gupta@gla.ac.in.
- Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India.
ORCID-Profile: Jitendra Gupta, Gaurang Sharma
Zitieren
APA
Gupta, J., & Sharma, G. (2025). Nanogel: A versatile drug delivery system for the treatment of various diseases and their future perspective. Drug Delivery and Translational Research, 15(2), 455-482. https://doi.org/10.1007/s13346-024-01684-w
Vancouver
Gupta J, Sharma G. Nanogel: A versatile drug delivery system for the treatment of various diseases and their future perspective. Drug Delivery and Translational Research. 2025;15(2):455-482. doi:10.1007/s13346-024-01684-w
BibTeX
@article{Gupta2025,
author = {Gupta, Jitendra and Sharma, Gaurang},
title = {Nanogel: A versatile drug delivery system for the treatment of various diseases and their future perspective},
journal = {Drug Delivery and Translational Research},
year = {2025},
volume = {15},
number = {2},
pages = {455--482},
doi = {10.1007/s13346-024-01684-w}
}
EUVIMED